1. Japan Stocks

  2. •

    Consumer Defensive

  3. •

    Household & Personal Products
C.I. Medical Co.,Ltd.

C.I. Medical Co.,Ltd.

3540.T
C.I. Medical Co.,Ltd.JP flagTokyo Stock Exchange
1,493.00
JPY
+1.00
- -
74.65BMarket Cap

Total Valuation

C.I. Medical Co.,Ltd. carries a market capitalization of 74.65B, placing it among publicly traded companies globally. Its enterprise value stands at 58.85B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap74.65B
Enterprise Value58.85B

Share Statistics

C.I. Medical Co.,Ltd. currently has 50.00M shares outstanding.

Shares Outstanding50.00M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

C.I. Medical Co.,Ltd. trades at a trailing price-to-earnings ratio of 31.96. The price-to-sales ratio is 0.96, and the price-to-book ratio stands at 2.24.

PE Ratio31.96
PS Ratio0.96
PB Ratio2.24
P/TBV Ratio2.42
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, C.I. Medical Co.,Ltd. trades at an EV/EBITDA multiple of 26.70 and an EV/FCF ratio of 3,426.83. The EV/Sales ratio of 1.23 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 26.70 provides insight into valuation relative to core operating earnings.

EV / Sales1.23
EV / EBITDA26.70
EV / EBIT26.70
EV / FCF3,426.83

Financial Position

C.I. Medical Co.,Ltd. maintains a current ratio of 0.89, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 93.63, indicating elevated leverage, while an interest coverage ratio of 84.77 demonstrates strong ability to service its debt obligations.

Current Ratio0.89
Quick Ratio0.27
Debt / Equity93.63
Debt / EBITDA8.71
Interest Coverage84.77

Financial Efficiency

C.I. Medical Co.,Ltd. posts a return on equity of 7.23 and a return on invested capital of 4.34.

Return on Equity (ROE)7.23
Return on Assets (ROA)3.49
Return on Invested Capital (ROIC)4.34
Return on Capital Employed (ROCE)4.30
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover4.28

Taxes

Over the trailing twelve months, C.I. Medical Co.,Ltd. has paid 751.00M in income taxes, reflecting an effective tax rate of 33.95.

Income Tax751.00M
Effective Tax Rate33.95

Stock Price Statistics

C.I. Medical Co.,Ltd.'s stock has gained approximately 74.82436% over the past 52 weeks. The 50-day moving average sits at 7.46B, while the 200-day moving average is 5.90B.

Beta (5Y)N/A
52-Week Price Change74.82436%
50-Day Moving Average7.46B
200-Day Moving Average5.90B
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, C.I. Medical Co.,Ltd. generated 47.75B in revenue and converted that into 1.43B in net income, yielding earnings per share of 29.22. EBITDA reached 2.20B, while operating income came in at 2.20B.

Revenue47.75B
Gross Profit12.29B
Operating Income2.20B
Pretax Income2.21B
Net Income1.43B
EBITDA2.20B
EBIT2.20B
Earnings Per Share (EPS)29.22

Balance Sheet

C.I. Medical Co.,Ltd. holds 6.24B in cash and equivalents against 19.21B in total debt, resulting in a net debt position of 13.08B. Total book value stands at 20.41B, with working capital of -2.49B providing operational flexibility.

Cash & Cash Equivalents6.24B
Total Debt19.21B
Net Debt13.08B
Equity (Book Value)20.41B
Book Value Per Share408.32
Working Capital-2.49B

Margins

C.I. Medical Co.,Ltd. operates with a gross margin of 25.73, reflecting its pricing power and cost economics. The operating margin of 4.62 and net profit margin of 3.00 provide insight into operational efficiency.

Gross Margin25.73
Operating Margin4.62
Pretax Margin4.63
Profit Margin3.00
EBITDA Margin4.62

Stock Splits

C.I. Medical Co.,Ltd.'s most recent stock split took place on June 27, 2024 with a 1:5 split ratio.

Last Split Date6/27/2024
Split Ratio1:5

Scores

C.I. Medical Co.,Ltd. posts an Altman Z-Score of 3.04, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.04